Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells
NCT01548274 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2012-03-08
Summary
The purpose of this study is to evaluate the effects of Sarpogrelate in endothelial progenitor cells of patients with atherosclerosis.
Conditions
Interventions
- DRUG
-
Sarpogrelate
Sarpogrelate 300mg/day
Sponsors & Collaborators
-
Aichi Gakuin University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- Japan
Study Locations
More Related Trials
-
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
NCT07282041 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Rilonacept to Improve Artery Function in Patients With Atherosclerosis
NCT00417417 ·Status: COMPLETED ·Phase: PHASE2
-
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles
NCT04616872 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4
-
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
NCT00745914 ·Status: COMPLETED ·Phase: NA
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT03254446 ·Status: UNKNOWN ·Phase: PHASE3
-
GLPG0492 Pharmacodynamics
NCT01538420 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
NCT04848220 ·Status: TERMINATED ·Phase: PHASE2
-
Carnosine for Peripheral Arterial Disease Patients
NCT05371145 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT06816264 ·Status: COMPLETED ·Phase: PHASE2
-
TART - Troglitazone Atherosclerosis Regression Trial
NCT00116545 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT02378064 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients
NCT01061060 ·Status: COMPLETED ·Phase: PHASE4
-
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
NCT01321476 ·Status: WITHDRAWN
-
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
NCT05975554 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
NCT04277702 ·Status: UNKNOWN ·Phase: PHASE3
-
PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
NCT03159559 ·Status: UNKNOWN ·Phase: PHASE4
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
The Role of Pioglitazone in Vascular Transcriptional Remodeling
NCT05775380 ·Status: RECRUITING ·Phase: PHASE4
-
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
NCT00424866 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia
NCT02928094 ·Status: UNKNOWN ·Phase: PHASE3
-
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
NCT01575288 ·Status: COMPLETED ·Phase: NA
-
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 ·Status: TERMINATED ·Phase: PHASE3